 Stacey Seggelke
Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nurse Practitioners | 2 | 2025 | 132 | 1.120 |
Why?
| | Hypoglycemic Agents | 8 | 2025 | 1220 | 0.920 |
Why?
| | Nurse Clinicians | 1 | 2025 | 43 | 0.900 |
Why?
| | Physician Assistants | 1 | 2025 | 89 | 0.850 |
Why?
| | Diabetes Mellitus, Type 2 | 9 | 2025 | 2441 | 0.830 |
Why?
| | Hyperglycemia | 5 | 2024 | 328 | 0.720 |
Why?
| | Diabetes Mellitus | 5 | 2014 | 1001 | 0.600 |
Why?
| | Cardiovascular System | 1 | 2017 | 137 | 0.500 |
Why?
| | Insulin Glargine | 3 | 2014 | 81 | 0.470 |
Why?
| | Blood Glucose | 7 | 2025 | 2097 | 0.420 |
Why?
| | Medically Uninsured | 1 | 2014 | 127 | 0.410 |
Why?
| | Insulin, Isophane | 2 | 2024 | 21 | 0.410 |
Why?
| | Hospitals | 1 | 2017 | 637 | 0.400 |
Why?
| | Patient Preference | 1 | 2014 | 185 | 0.380 |
Why?
| | Continuity of Patient Care | 1 | 2014 | 275 | 0.370 |
Why?
| | Methylprednisolone | 1 | 2011 | 83 | 0.350 |
Why?
| | Medicaid | 1 | 2014 | 433 | 0.320 |
Why?
| | Hospitalization | 5 | 2025 | 2070 | 0.300 |
Why?
| | Quality Improvement | 1 | 2014 | 1103 | 0.240 |
Why?
| | Insulin, Long-Acting | 3 | 2024 | 62 | 0.240 |
Why?
| | Cystic Fibrosis | 2 | 2012 | 1053 | 0.230 |
Why?
| | Focus Groups | 1 | 2025 | 453 | 0.200 |
Why?
| | Academic Medical Centers | 1 | 2025 | 481 | 0.190 |
Why?
| | Hypoglycemia | 2 | 2024 | 427 | 0.170 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2014 | 3628 | 0.160 |
Why?
| | Burnout, Professional | 1 | 2025 | 410 | 0.150 |
Why?
| | Enteral Nutrition | 3 | 2024 | 188 | 0.150 |
Why?
| | Qualitative Research | 1 | 2025 | 1235 | 0.150 |
Why?
| | Pilot Projects | 2 | 2014 | 1587 | 0.140 |
Why?
| | Pandemics | 1 | 2025 | 1488 | 0.130 |
Why?
| | Medical Staff, Hospital | 1 | 2016 | 78 | 0.130 |
Why?
| | Humans | 15 | 2025 | 129652 | 0.120 |
Why?
| | Middle Aged | 9 | 2025 | 31155 | 0.110 |
Why?
| | Female | 9 | 2025 | 68777 | 0.110 |
Why?
| | Advanced Practice Nursing | 1 | 2013 | 34 | 0.100 |
Why?
| | Clinical Trials as Topic | 1 | 2017 | 1004 | 0.100 |
Why?
| | Biphasic Insulins | 1 | 2011 | 3 | 0.100 |
Why?
| | Critical Illness | 2 | 2024 | 758 | 0.100 |
Why?
| | Insulin Lispro | 1 | 2011 | 39 | 0.090 |
Why?
| | Patient Care Team | 1 | 2016 | 605 | 0.090 |
Why?
| | Education, Nursing, Continuing | 1 | 2011 | 49 | 0.090 |
Why?
| | Patient Admission | 1 | 2012 | 182 | 0.090 |
Why?
| | Inpatients | 1 | 2012 | 467 | 0.070 |
Why?
| | Patient Readmission | 1 | 2014 | 667 | 0.070 |
Why?
| | Prediabetic State | 1 | 2011 | 246 | 0.070 |
Why?
| | Patient Discharge | 1 | 2014 | 857 | 0.070 |
Why?
| | Aged | 5 | 2025 | 22104 | 0.060 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 1501 | 0.060 |
Why?
| | Male | 7 | 2025 | 63682 | 0.060 |
Why?
| | Colorado | 1 | 2014 | 4421 | 0.050 |
Why?
| | Risk Factors | 1 | 2017 | 9765 | 0.050 |
Why?
| | Retrospective Studies | 5 | 2024 | 14518 | 0.050 |
Why?
| | Adult | 6 | 2016 | 35577 | 0.050 |
Why?
| | Patient Care Management | 1 | 2001 | 56 | 0.040 |
Why?
| | Hypothyroidism | 1 | 2001 | 70 | 0.040 |
Why?
| | Thyroid Gland | 1 | 2001 | 94 | 0.040 |
Why?
| | Specialization | 1 | 2001 | 145 | 0.040 |
Why?
| | Medicine | 1 | 2001 | 119 | 0.040 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2025 | 601 | 0.040 |
Why?
| | Insulin | 2 | 2024 | 2326 | 0.040 |
Why?
| | Insulin Infusion Systems | 2 | 2012 | 363 | 0.040 |
Why?
| | Glucose | 1 | 2024 | 1003 | 0.040 |
Why?
| | United States | 1 | 2014 | 13903 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2011 | 2012 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2012 | 147 | 0.020 |
Why?
| | Primary Health Care | 1 | 2001 | 1680 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2016 | 7086 | 0.020 |
Why?
| | Young Adult | 2 | 2012 | 12427 | 0.020 |
Why?
| | Thyroxine | 1 | 2001 | 62 | 0.010 |
Why?
| | Thyrotropin | 1 | 2001 | 109 | 0.010 |
Why?
| | Prospective Studies | 1 | 2012 | 7133 | 0.010 |
Why?
| | Data Collection | 1 | 2001 | 650 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2012 | 10230 | 0.010 |
Why?
| | Autoantibodies | 1 | 2001 | 1466 | 0.010 |
Why?
|
|
Seggelke's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|